logo

AMRZ

Amrize·NYSE
--
--(--)
--
--(--)
3.32 / 10
Netural

Fundamental health is subpar, scoring 3.3/10. Positive drivers include PB‑ROE and Cash‑UP, while Revenue‑MV and Profit‑MV lag. Asset‑MV shows moderate strength, but overall constraints limit upside.

Fundamental(3.32)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value0.11
Score1/3
Weight9.42%
1M Return8.71%
ROA (%)
Value4.92
Score2/3
Weight6.45%
1M Return7.01%
Annualized return on equity (%)
Value10.23
Score2/3
Weight6.04%
1M Return6.72%
Profit-MV
Value0.75
Score0/3
Weight1.38%
1M Return1.61%
PB-ROE
Value0.17
Score2/3
Weight14.06%
1M Return11.37%
Cash-UP
Value0.73
Score3/3
Weight14.36%
1M Return11.94%
Annualized net profit margin on total assets (%)
Value4.92
Score2/3
Weight6.45%
1M Return7.01%
Asset-MV
Value-0.48
Score2/3
Weight21.99%
1M Return18.64%
ROE (%)
Value10.23
Score2/3
Weight6.04%
1M Return6.72%
Cash-MV
Value1.13
Score2/3
Weight13.82%
1M Return13.11%
Is AMRZ undervalued or overvalued?
  • AMRZ scores 3.32/10 on fundamentals and holds a Fair valuation at present. Backed by its 10.23% ROE, 10.00% net margin, 26.21 P/E ratio, 2.34 P/B ratio, and -6.96% earnings growth, these metrics solidify its Netural investment rating.